Log in to save to my catalogue

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1c39e9c570e476f9b53726a026c917a

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin

About this item

Full title

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-08, Vol.11 (1), p.15878-15878, Article 15878

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Bacterial endophthalmitis is a rare intraocular infection, and prompt administration of intravitreal antibiotics is crucial for preventing severe vision loss. The retrospective study is to investigate the in vitro susceptibility to the antibiotics vancomycin, amikacin, and ceftazidime of bacterial endophthalmitis isolates in specimens at a tertiary...

Alternative Titles

Full title

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a1c39e9c570e476f9b53726a026c917a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1c39e9c570e476f9b53726a026c917a

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-95458-w

How to access this item